Litigation Details for Janssen Pharmaceuticals, Inc. v. Tolmar, Inc. (D. Del. 2021)
Janssen Pharmaceuticals, Inc. v. Tolmar, Inc. (D. Del. 2021)
| Docket | ⤷ Start Trial | Date Filed | 2021-12-21 |
| Court | District Court, D. Delaware | Date Terminated | 2026-05-06 |
| Cause | 35:271 Patent Infringement | Assigned To | William C. Bryson |
| Jury Demand | None | Referred To | Sherry R. Fallon |
| Patents | 10,016,435; 9,439,906 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Janssen Pharmaceuticals, Inc. v. Tolmar, Inc.
Details for Janssen Pharmaceuticals, Inc. v. Tolmar, Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-12-21 | External link to document | |||
| 2021-12-21 | 114 | Order - Memorandum and Order AND ~Util - Terminate Motions | U.S. Patent No. 9,439,906 (“the ’906 patent”) against Tolmar in this action. The ’906 patent is generally…loading dose. ’906 patent, cl. 1. On its face, the ’906 patent claims priority to one …applicant for a patent.” Accordingly, the key question is whether the claims of the ’906 patent are entitled…AND ORDER In this Hatch-Waxman Act patent case, plaintiffs Janssen Pharmaceuticals Inc. and…dispute the priority date of the claims of the ’906 patent. For purposes of the present motion, claim | External link to document |
| 2021-12-21 | 124 | In Limine | proceedings regarding U.S. Patent No. 9,439,906 (“the ‘906 patent”), including but not limited to…proceedings regarding [U.S. Patent No. 9,439,906] (the “906 Patent”).” Tolmar’s Motion in Limine to…Other Litigation Proceedings Regarding U.S. Patent No. 9,439,906 - filed by Tolmar, Inc.. (Poff, Adam) (Entered… PROCEEDINGS REGARDING U.S. PATENT NO. 9,439,906 Case 1:21-cv-01784-WCB-SRF Document 124 … PROCEEDINGS REGARDING U.S. PATENT NO. 9,439,906 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
